Mp33-19 a Transfusion Dashboard Initiative Safely Reduces Unnecessary Group and Screen Testing for Endourologic Procedures

You have accessJournal of UrologyHealth Services Research: Quality Improvement & Patient Safety II (MP33)1 May 2024MP33-19 A TRANSFUSION DASHBOARD INITIATIVE SAFELY REDUCES UNNECESSARY GROUP AND SCREEN TESTING FOR ENDOUROLOGIC PROCEDURES Ghizlane Moussaoui, Jacqueline D. Trudeau, Emma Pienaar, and Connor M. Forbes Ghizlane MoussaouiGhizlane Moussaoui , Jacqueline D. TrudeauJacqueline D. Trudeau , Emma PienaarEmma Pienaar , and Connor M. ForbesConnor M. Forbes View All Author Informationhttps://doi.org/10.1097/01.JU.0001009520.30626.80.19AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: Group and screen (G&S) testing is routinely performed pre-operatively for many endoscopic procedures, despite a low rate of blood transfusion. While important, testing can be costly, unnecessary and burdensome to patients to obtain G&S in a short timeframe due to expiry. We aimed to assess and reduce unnecessary G&S testing in a safe and collaborative manner through a Transfusion Dashboard. We assessed the effect of reduced G&S testing on cost and the environment. METHODS: The Transfusion Dashboard (TD), launched at UBC in 2020, is a quality improvement initiative which tracks procedure-specific transfusion rates. Based on initial findings, recommendations for pre-operative G&S for endoscopic procedures were developed. We reviewed incidence of G&S testing, perioperative transfusion rates and rescue transfusion rates (when a patient without G&S needs urgent, uncrossed transfusion) in endourological procedures before and after the implementation of this initiative with the chi-squared test. We also assessed cost and environmental savings. RESULTS: From 2016-2023, outcomes were tracked for 4393 pre-TD initiative and 2058 post-TD initiative patients who underwent endoscopic procedures (Table 1). We found a statistically significant decrease in G&S testing post-TD for TURP, PNL, HoLEP, and TURBT by as much as 63.6% (Table 1, p<0.001). There was no change in uncrossed or overall blood transfusions (0% for all groups). In 2022, for TURP alone, this resulted in a total saving of $1947 and reduction of 40Kg in CO2 emissions by eliminating 75 patient visits to the laboratory. CONCLUSIONS: Institutional and procedure specific G&S testing guidelines decrease unnecessary tests, leading to improved resource stewardship, reduced cost, respecting patients' time, and environmental savings. While the cost savings per group is modest, care improvements may be amplified safely in larger organizations and across more procedures. Source of Funding: None © 2024 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 211Issue 5SMay 2024Page: e568 Advertisement Copyright & Permissions© 2024 by American Urological Association Education and Research, Inc.Metrics Author Information Ghizlane Moussaoui More articles by this author Jacqueline D. Trudeau More articles by this author Emma Pienaar More articles by this author Connor M. Forbes More articles by this author Expand All Advertisement PDF downloadLoading ...